Resistant Hypertension

Baroness Blackwood of North Oxford Excerpts

Wednesday 24th June 2026 Lords Chamber

[Baroness Merron (Lab)]

I certainly would agree with that. Indeed, those who are diagnosed with resistant hypertension—and the noble Lord has, as ever, outlined how that is defined in a far better way than I could have done—can be referred by their GP to secondary care hospital hypertension services, so, to answer the point made by the noble Lords, Lord Patel and Lord Evans, that does mean in-depth investigations and expert management. The House can be assured of that.

[Baroness Blackwood of North Oxford (Con)]

My Lords, I declare my interest as chair of the Health Data Research Service. We know that hypertension remains underdiagnosed, and it is right that the Government have diversified the detection pathways. However, between those first high recordings at a pharmacy or in social care, the information does not always flow through to the treatment location, so people remain undertreated as well as underdiagnosed. Can the Minister say what steps the department will take to address this failing?

[Baroness Merron (Lab)]

That clearly matters immensely. We have invested in community pharmacy services, which have brought this into the heart of communities and made it easier and more attractive for people to have their blood pressure checked. As of February, we have some 10,000 community pharmacies delivering. We are also developing the online NHS health check and the modern service framework. Information from pharmacies should be going direct to GPs, but I am heartened, as we move towards the health Bill, by the advent of the single patient record.